Anabolic steroid use has been associated with kidney injury, including sudden loss of kidney function and scarring of the kidney filters. The human evidence includes small clinical series, not a reliable percentage risk for every user. A high creatinine result can reflect muscle and supplement effects, kidney disease, or both. Blood pressure, urine tests and the change from earlier results help a clinician separate those possibilities.
What the kidney evidence can tell you
Kidney damage is an umbrella term. A problem in the filters, an abrupt injury to the tubules and an altered blood marker are different findings. Treating them as interchangeable can cause both needless alarm and missed illness.
| Finding | Evidence | What it cannot establish |
|---|---|---|
| Scarring of kidney filters | Biopsies in a selected series of bodybuilders exposed to AAS. | The proportion of all users who will develop scarring. |
| Acute tubular injury | Four clinical cases involving anabolic steroids and substantial supplement use. | Which exposure caused the injury by itself. |
| Kidney injury during severe liver illness | Individual reports of bile acid nephropathy. | A usual outcome of every oral steroid or every episode of jaundice. |
| Raised creatinine | A blood marker affected by filtration and by creatinine production. | A diagnosis, cause or prognosis from one number. |
These findings justify clinical attention. They do not identify a kidney safe steroid, a protective cycle length or a test result that permits continued nonmedical use. Prescribed testosterone treatment and combinations used for physique change also differ in exposure, product control and patient selection.
A July 2026 review of AAS and acute kidney injury reports that the true prevalence remains unknown and direct kidney toxicity is less clear than some other steroid harms. The authors describe indirect injury pathways in reported cases. Mechanistic explanations should not be presented as a measured risk for an individual.
Filter damage, protein leakage and FSGS
In a 2010 report by Herlitz and colleagues, ten bodybuilders with prolonged anabolic steroid exposure had proteinuria and impaired kidney function. Nine had focal segmental glomerulosclerosis (FSGS), a pattern of scarring in parts of some kidney filters; the remaining person had enlarged filters without FSGS. This was a selected clinical series, not a survey of all steroid users.
The authors proposed contributions from increased body mass and possible steroid toxicity. The study could not isolate a single cause. Eight people had follow up: one progressed to kidney failure; the other seven received treatment and stopped AAS, with reduced protein leakage and stable or improved creatinine. One later resumed AAS and relapsed. Several changes occurred together, so this is not proof that stopping alone reverses established scarring.
Protein leakage deserves assessment even when you feel well. A kidney biopsy can identify a tissue pattern, but its name does not by itself identify the cause or tell every patient how much function will return.
Sudden injury, muscle breakdown and liver illness
A 2015 report of four bodybuilders described acute tubular necrosis, meaning injury to the small kidney tubules, during concurrent anabolic steroid, protein and creatine use. Creatinine improved after the exposures were withdrawn. Two biopsies also showed substantial chronic tissue changes. Improved blood results did not erase those findings, and multiple exposures prevented a clean comparison of steroids against supplements.
Acute kidney injury (AKI) can develop when blood flow falls, urine drainage is blocked or kidney tissue is injured. Dehydration, infection and existing heart, liver or kidney disease can contribute. A clinician must check for these causes instead of assigning every abnormal result to AAS. The NHS account of AKI describes this range of causes and the need for prompt assessment.
Rhabdomyolysis is muscle breakdown that can damage the kidneys. Unusually severe muscle pain, tea or cola coloured urine, or marked weakness after exertion can signal it; all three do not have to occur together. CDC advice on rhabdomyolysis calls for immediate medical care for suspected symptoms. Clinicians use blood creatine kinase (CK) and may repeat it. A normal looking urine sample or a negative urine dipstick does not reliably exclude rhabdomyolysis.
Liver and kidney injury can also coincide. A 2021 case report described bile acid nephropathy in a man with severe bilirubin elevation after liver injury attributed to anabolic steroids. This supports a possible pathway involving severe cholestasis, or impaired bile flow, rather than a risk estimate for all users. The separate liver health page covers that organ’s warning signs.
Why creatinine can be misleading
Creatinine comes partly from muscle metabolism. Laboratories use it to calculate estimated glomerular filtration rate, or eGFR, an estimate of how much blood the kidneys filter. More muscle, recent strenuous exercise, cooked meat and creatine supplements can raise creatinine without an equivalent fall in filtration. Some medicines affect the result too. The National Kidney Foundation’s creatinine explanation describes these influences.
An automated low eGFR is not automatically false because you lift weights. Nor does creatinine inside the laboratory range exclude kidney disease. Share earlier results, recent training, food and supplement use with the clinician. Follow the laboratory’s preparation instructions; do not manipulate intake or postpone urgent testing to obtain a better looking number.
Creatine and creatinine are different substances. Declaring creatine use helps interpret a test; it does not establish that the supplement caused an injury or that all supplements are harmless. A rising value during illness needs assessment, even if muscle mass has complicated past tests.
Where cystatin C helps, and where it does not
Cystatin C is another blood marker used to estimate filtration. It can add information when creatinine is difficult to interpret, but it is not an infallible answer. The National Kidney Foundation notes limitations with untreated thyroid conditions and steroid treatment.
The KDIGO 2024 recommendations distinguish extra muscle alone from anabolic or hormone steroid exposure. For the latter, the effect on cystatin C is uncertain and a combined creatinine and cystatin C estimate is suggested. A specialist may use measured GFR when greater accuracy would change care. Choosing whichever estimate looks healthiest is not a valid way to settle disagreement between results.
A 2023 study of 24 bodybuilders compared 12 using AAS and supplements with 12 using supplements alone. The AAS group had lower cystatin C estimates of filtration and higher urinary albumin and protein excretion. This small comparison supports looking beyond creatinine alone; it does not prove that AAS caused each difference or predict future kidney failure.
The dedicated page on creatinine, eGFR and cystatin C covers the testing question in more detail. Ask which estimate your report uses and what could affect it in your circumstances.
Urine results and the timeline complete the picture
Blood filtration tests and urine albumin tests answer different questions. Albumin is a blood protein that can leak into urine when kidney filters are damaged. Urine albumin to creatinine ratio, called ACR or uACR, quantifies that leakage. NIDDK explains why clinicians use both blood and urine tests and may repeat abnormal urine findings.
Albumin can appear in urine while eGFR remains above 60. Exercise, dehydration, fever and infection can cause temporary increases. The National Kidney Foundation’s albuminuria information separates temporary findings from persistent disease. Foamy urine can prompt a test, but its appearance cannot measure albumin or diagnose FSGS.
CKD means a kidney abnormality persists for at least three months. A single abnormal eGFR or ACR does not establish that duration. KDIGO advises checking earlier records and repeating measurements as appropriate. This definition is not an instruction to wait three months when an acute injury is possible. Urgent symptoms or a rapid change need earlier assessment.
The clinician may also assess potassium and other electrolytes, urine blood, blood pressure and fluid balance. Ultrasound or other investigations depend on the suspected cause; not everyone needs the same package. See blood testing for steroid users for how renal results fit beside other health checks.
Blood pressure, medicines and other exposures
Kidney assessment includes blood pressure. In February 2025 the FDA required testosterone labelling changes about increased blood pressure following monitoring studies. This does not quantify the renal risk of a particular nonmedical steroid combination. Record repeated readings and bring them to care; the blood pressure monitoring page explains measurement and escalation.
The US XYOSTED testosterone enanthate label warns about fluid retention, potentially serious in people with existing kidney, cardiac or liver disease. Swelling is not proof of kidney failure, but it should not be dismissed as an expected cosmetic effect.
Ibuprofen, naproxen and other nonsteroidal anti inflammatory drugs can affect kidney blood flow, especially during dehydration or illness. Prescribed medicines for blood pressure may protect the kidneys yet need review during fluid loss. NIDDK’s medicine advice supports discussing the complete list with a clinician or pharmacist and having a plan for illness. Do not stop prescribed treatment, borrow a diuretic or add potassium supplements to correct a result yourself.
Report prior kidney injury or disease, diabetes, high blood pressure, heart disease and a family history of kidney failure. Mention a single kidney, stones or urinary obstruction as part of your medical history. Include weight cutting, heavy exercise, heat exposure, alcohol, recreational drugs, growth hormone, supplements and every product sold as a steroid. Unknown ingredients limit what any interaction assessment can establish.
When symptoms need attention
Persistent foamy urine, repeated high blood pressure or an unexplained abnormal test also warrants a clinical appointment. Early kidney disease may produce no symptoms, so normal urine output and feeling strong are not substitutes for testing.
Recovery and the next medical appointment
Recovery depends on the type of injury, its severity, prior kidney health and treatment. Some acute injuries recover; others leave lasting damage. Follow up remains necessary after blood results improve. Scarring and repeated injury can change the outlook, and neither a case report nor one normal test can predict an individual’s recovery.
If CKD is diagnosed, management addresses its cause, blood pressure, medicines and nutrition. NIDDK describes continuing kidney care, including working with the healthcare team on medicines and an appropriate eating plan. A renal dietitian can tailor advice; there is no universal protein, fluid or supplement plan that makes AAS use safe. Do not attempt a water flush to treat reduced urine or swelling.
- Bring dated blood and urine reports, including any results before steroid exposure.
- List products, amounts used, timing, changes and the last exposure. Include medicines and supplements, not only AAS.
- Record when symptoms began, urine changes, recent illness, training and any blood pressure readings.
- Ask which findings need urgent action, which need repeat testing and who will review the results.
- Discuss stopping nonmedical exposure with medical support, including withdrawal symptoms and mental health needs.
Use the medical appointment preparation page to organise that history. You do not need to prove that steroids caused the problem before seeking care.